Oligomycin
- 貨號 Cat. No.
- O-500
- 規格 Size
- 10 x 1 mg 5mg 5x5mg
Description
Oligomycin
Mitochondrial ATP Synthase Inhibitor
| Product#: | O-500 |
| Sizes: |
| 10 x 1 mg |
| 5 mg |
| 5 x 5 mg |
| M.W.: | 789.3 |
| CAS No.: | [14110-64-6] |
| Structure: |
![]() |
| Bioassay: |
| Oligomycin inhibits ATP dependent adipogenesis in 3T3-L1 cells. 3T3-L1 preadipocytes were induced to undergo adipocyte differentiation (A-D). 5 days post differentiation, different concentrations of Oligomycin (#O-500) were added (A=0, B=1, C=2, and D=10mg/ml). After 10 days the cells were stained with Oil Red 0 and visualized by light microscopy. |
![]() |
| References: |
1. | Chappell, J.B. and Greville, G.D. (1961) Nature 190, 502. |
2. | Kagawa, Y. and Racker, E. (1966) J. Biol. Chem. 241, 2461. |
3. | Kim, S.B. and Berdanier, C.D. (1999) Am. J. Physiol. Endocrinol. Metab. 277, E702. |
4. | Cunningham, C.C. and George, D.T. (1975) J. Biol. Chem. 250, 2036. |
5. | Arato-Oshima, T. et al. (1996) J. Biol. Chem. 271, 25604. |
6. | Fortes, P.A. and Lee, J.A. (1984) J. Biol. Chem. 259, 11176. |
7. | Garrahan, P.J. and Glynn, I.M. (1967) J. Physiol. 192, 217. |
8. | Cornelius, F. and Skou, J.C. (1985) Biochim. Biophys. Acta 818, 211. |
9. | Martin, W.H. et al. (1994) Proc. Natl. Acad. Sci USA 91, 9881. |
10. | Hegyvary, C. (1976) Biochim. Biophys. Acta 422, 365. |
11. | Fahn, S. et al. (1966) J. Biol. Chem. 241, 1882. |
12. | Fahn, S. et al. (1968) J. Biol. Chem. 243, 1993. |
13. | Inturrisi, C.E. and Titus, E. (1968) Mol. Pharmacol. 4, 591. |
Oligomycin is a natural antibiotic isolated from Streptomyces diastatochromogenes
Oligomycin inhibits the H+- ATP-synthase by binding to the Oligomycin sensitivity-conferring protein (OSCP) at the F(o) subunits 6 and 9 which are found in the stalk of the F1F0-ATPase complex. This binding blocks the proton conductance and inhibits the synthesis of mitochondrial ATP.3-4 Because of its activity, it can also be used to reduce the number of parameters (such as ER Ca2+ release, exocytotoxicity and apopotosis) which are affected by mitochondrial depolarization.5
Oligomycin at high concentrations may also inhibit the plasma membrane Na+-K+-ATPase. Interaction of Oligomycin with the Na+ occlusion site on the extracellular side of Na/K-ATPase, delays Na+ release to the extracellular side without inducing a conformational change. Although Oligomycin stimulated Na+ binding to Na+/K+-ATPase, it inhibited Na+/Na+ exchange, and did not affect either Na+-dependent AD/-ATP exchange or K+-dependent phosphatase activity.
_str.gif)
